Journal
CURRENT OPINION IN RHEUMATOLOGY
Volume 32, Issue 2, Pages 192-199Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/BOR.0000000000000685
Keywords
autoimmune disease; fatty acid oxidation; glutaminolysis; glycolysis; T cell
Categories
Funding
- NIH [R01AR064350, R37 AI 49954]
- SENSHIN Medical Research Foundation grant
- Japan Society for the promotion of science postdoctoral fellowships research abroad
Ask authors/readers for more resources
Purpose of review Th1, Th17, and Treg cells play distinct roles in autoimmune diseases, including systemic lupus erythematosus, multiple sclerosis, and rheumatoid arthritis. During the last 5 years we have learned that T-cell metabolism affects cell survival, differentiation and fate of T cells. Recent findings We highlight recent studies which have reported on T-cell metabolism in autoimmune diseases, differences in cellular metabolisms in T-cell subsets among various diseases and transcription factors which control the expression and function of central metabolic enzymes. Distinct metabolic processes control the function of T-cell subsets in autoimmune disease and known transcription factors control the activity of metabolic enzymes. The revealed insights into the metabolic events of immune cells offer opportunities for new therapeutic approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available